Rutacid chewable tablets 500mg, # 20

• Hyperacidity of gastric juice,

• heartburn,

• gastritis,

• peptic ulcer and 12 duodenal ulcer,

• reflux esophagitis.

Inside, chewing thoroughly.

Adults and children over 12 years old: 1-2 tables. 1 hour after meals 3-4 times a day and before bedtime.

Children from 6 to 12 years old: 1 table. 2 times a day.

Treatment should be continued for 4 weeks.

1 tablet contains:

Active substance:

Hydrotalcite - 500.00 mg

Excipients:

Mannitol - 836.00 mg

Sodium saccharinate - 0.60 mg

Sodium carboxymethyl starch - 12.00 mg

Talc - 35.00 mg

Magnesium stearate - 14.00 mg

Mint flavor - 2.40 mg

• Individual hypersensitivity to drug components,

• children's age (up to 6 years).

With care : chronic renal failure, hypophosphatemia.

Tradename:

RutacidЃ

International Non-Proprietary Name (INN):

hydrotalcite

Dosage form:

chewable tablets

Composition

1 tablet contains:

Active substance:

Hydrotalcite - 500.00 mg

Excipients:

Mannitol - 836.00 mg

Sodium saccharinate - 0.60 mg

Sodium carboxymethyl starch - 12.00 mg

Talc - 35.00 mg

Magnesium stearate - 14.00 mg

Mint flavor - 2.40 mg

Description

Round tablets of white or almost white color with a bevel, with a slight mint odor.

Pharmacotherapeutic group:

antacid

ATX code : A02AD04

Pharmacological properties

Hydrotalcite has a layered network structure with a low content of aluminum and magnesium. The release of aluminum and magnesium ions occurs gradually, depending on the pH of the gastric juice. The drug provides fast and long-term neutralization of hydrochloric acid while maintaining the pH close to normal. It has a protective effect on the gastric mucosa. Reduces the proteolytic activity of pepsin, binds bile acids.
Pharmacokinetics
The release of magnesium and aluminum ions occurs in the stomach gradually, depending on the pH value. Hydrotalcite is absorbed in the small intestine. After oral administration, the content of magnesium and aluminum ions in the blood plasma temporarily increases, but penetration into the nervous and bone tissue does not occur (with normal renal function). The absorbed portion is excreted by the kidneys.

Indications for use

• Hyperacidity of gastric juice,

• heartburn,

• gastritis,

• peptic ulcer and 12 duodenal ulcer,

• reflux esophagitis.

Contraindications

• Individual hypersensitivity to drug components,

• children's age (up to 6 years).

With care : chronic renal failure, hypophosphatemia.

Application during pregnancy and during breastfeeding

There are no confirmed data on the undesirable effect of hydrotalcite during pregnancy and breastfeeding.
The use of the drug RutacidЃ during pregnancy is permitted if the potential benefit to the mother outweighs the possible risk to the fetus.
The drug RutacidЃ does not penetrate into breast milk, so its use is possible during breastfeeding.

Method of administration and dosage

Inside, chewing thoroughly.
Adults and children over 12 years old: 1-2 tablets 1 hour after meals 3-4 times a day and before bedtime.
Children from 6 to 12 years old: 1 tablet 2 times a day.
Treatment should be continued for 4 weeks.

Side effect

When using the drug RutacidЃ in recommended doses, undesirable effects are rare.
Allergic reactions, diarrhea, belching are possible.

Overdose

No signs of intoxication due to drug overdose were reported.

Interaction with other medicinal products

Like other antacids, RutacidЃ can reduce the absorption of tetracyclines, quinolones (ciprofloxacin, ofloxacin), iron and coumarins, antibiotics.

special instructions

The interval between the use of RutacidЃ and other medicines should be at least 1-2 hours.
It is not recommended to use RutacidЃ simultaneously with acidic drinks (juices, wine).
RutacidЃ does not contain sucrose, therefore it can be taken by patients with diabetes mellitus.
Polyols (mannitol) can cause diarrhea.

Influence on the ability to drive vehicles and other complex mechanisms :

The drug RutacidЃ does not affect the ability to drive vehicles and other complex technical devices that require concentration of attention and speed of psychomotor reactions.

Release form

Chewable tablets, 500 mg.
10 tablets in a blister. 2 or 6 blisters are placed in a cardboard box together with instructions for use.

Storage conditions

At a temperature not higher than 30 ? C.
Keep out of the reach of children.

Shelf life

5 years.
Do not use after the expiration date.

Conditions of dispensing from pharmacies

Available without a prescription.